News
-
"Medicine safeguard missed," Bruce S. Rubin, M.D., Sarasota Herald Tribune, May 20, 2013
-
"Keep doctors informed and patients safe," Bruce S. Rubin, M.D., South Florida Sun-Sentinel, March 28, 2013
-
"Talking Biosimilars: Implementing Sound Policies to Ensure Patient Safety," Mass BIO, February 27, 2013
-
"Biotech Drugs Still Won't Copy," Wall Street Journal, February 26, 2013
-
"Biologics: Can Patients Get What the Doctor Orders? Challenges With Patient Access To Biological Medications Under The Current Healthcare Benefits Design," NPBWG white paper #2, December 2012
-
Taking Obamacare May Cause Side Effects, David Charles, M.D., Richmond Times-Dispatch, August 6, 2012
-
TREAT Act Offers Renewed Hope for Patients, BIO press release, February 15, 2012
-
NPBWG video: "The Benefits of Biologics," February 2012
-
FDA issues draft guidance on biosimilar product development, FDA news release, February 9, 2012
-
"Biologics: A Different Class of Medications that Make a Difference for Our Patients," NPBWG white paper, January 17, 2012
-
About the FDA and Biosimilars, Bruce S. Rubin, M.D., MedPage Today, November 4, 2011
-
Botox Games: Insurance Company Strategies to Make the Chronic Migraine Patient Lose, Alliance for Headache Disorders Advocacy blog, October 10, 2011
-
Drug costs, benefits must align; Patient safety demands tougher biologics standards, David Charles, M.D., The Tennessean, October 5, 2011
-
New Drugs Fight Prostate Cancer, but at High Cost, New York Times, June 27, 2011
-
Biologics Offer Hope to Arthritis Sufferers, Lakeland (Fla.) Ledger, May 27, 2011
-
Newer Arthritis Biologics Don't Raise Cancer Risk - Study, Wall Street Journal, May 25, 2011
-
FDA Officials Hint at Provisions of Biosimilar Guidances, Patent Docs blog, May 24, 2011
-
Safety of Biologics Varies, But Not By Much, Michael Slezak, Rheumatology update, May 23, 2011
-
New Prescription Drugs: New, riveting trends in drug development have emerged, Med City News, May 16, 2011
